Cleopatra Hospital Company’s capital increase approved by EGX Listing Committee
EGX Listing Committee approved yesterday Cleopatra Hospital Company’s (CHC) (CLHO.CA) EGP360mn capital increase that is distributed over 40mn shares at EGP9/share (EGP0.5 par value plus EGP8.5 share premium) and through a closed subscription to Care Healthcare Ltd., CHC’s major shareholder that owns c80% of the company post the capital increase. The company’s paid-in capital increased from EGP80mn to EGP100mn, accordingly. The capital increase is financed from the proceeds of the recent secondary offering, and the decision follows the AGM’S approval that was held on 6 April 2016 and as mentioned in CHC’S prospectus published in May 2016. (EGX disclosure) Cleopatra Hospital Company (CHC): EGP9.48 as of 17 August 2016, Rating: Buy, FV: EGP11.70 per share, MCap: USD171mn, CLHO EY / CLHO.CA
This website uses cookies to make the site work, to understand if the site is working well, how it is being used, to connect to social media sites (such as Facebook and Twitter) and to collect information useful to allow us and our partners to provide you with more relevant ads . Some cookies are essential to make the site work, but you can control how we use non-essential cookies at any time by clicking the “ON/OFF” button next to each category. For more information about the cookies used on this site, see Privacy Policy.
Decide which cookies you want to allow.
Strictly Necessary
These cookies are essential in order to enable you to move around our website and use its features, such as accessing secure areas of our website. Without these cookies, any services on our Site you wish to access cannot be provided.
Analytical/performance cookies
Visitors use our website, for instance which pages you go to most often, and if you get error messages from web pages.